Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

An investigation into the sharing of interim results of a randomized controlled trial with the investigator(s) of the trial, the sponsor of the trial and the steering committee of the trial.

EF 2013-14

Résumé
Data Safety Monitoring Boards (DSMB) are an independent group of experts that advise on the conduct of a randomized controlled trial (RCTs) while in progress. Their primary responsibilities are to review and evaluate incoming data during the interim of an RCT for participant safety, efficacy, conduct and progress, and to make recommendations to the trial investigators concerning trial continuation, modification and termination. An area of discussion pertinent to interim trial management pertains to the interim data analysis done by DSMBs and the potential sharing of interim data with other parties responsible for the conduct of the trial (e.g. principal investigators). It is unclear how combined interim outcomes are interpreted by trial investigators when they request such information from DSMBs. The question remains about what should be shared, with whom and when. Currently, there is paucity in the literature about sharing interim trial data. This research project's intent is to better understand what kind of interim RCT data should be shared by the DSMB, if anything at all should be shared, with the PIs, the sponsor, or the steering committee during the RCT by: 1) Performing a systematic review on the topic of interim data sharing; 2) Exploring the statistical and informational properties of different items that can be shared at interim; 3) Creating a survey that will then be delivered to those who have involvement or interest in RCTs to elicit their opinions with sharing interim data and; 4) Exploring demographic variables of the respondents to determine factors that are associated with their responses. This research is vitally important to help in providing clear guidelines for RCT protocols and DSMB operating procedures, as sharing such interim information may have consequences in regards to biasing the final results of the trial. Regulatory agencies may also find this information helpful to guide those registering or conducting trials for drug approval.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
314337
Name
Borg Debono Victoria
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
An investigation into the sharing of interim results of a randomized controlled trial with the investigator(s) of the trial, the sponsor of the trial and the steering committee of the trial.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Analysis Of Good Methodological Principles; Biostatistical Analysis; Data Safety Monitoring Board (Dsmb); Drug Safety And Effectiveness; Interim Data Analysis Of Rcts And Drug Trials; Policy Development Or Standard Operating Procedures For Rcts; Randomized Controlled Trial (Rct); Rct Protocols And Dsmb Charters; Survey Analysis Of Key Stakeholders In Rcts; Trialists
Abstract
Data Safety Monitoring Boards (DSMB) are an independent group of experts that advise on the conduct of a randomized controlled trial (RCTs) while in progress. Their primary responsibilities are to review and evaluate incoming data during the interim of an RCT for participant safety, efficacy, conduct and progress, and to make recommendations to the trial investigators concerning trial continuation, modification and termination. An area of discussion pertinent to interim trial management pertains to the interim data analysis done by DSMBs and the potential sharing of interim data with other parties responsible for the conduct of the trial (e.g. principal investigators). It is unclear how combined interim outcomes are interpreted by trial investigators when they request such information from DSMBs. The question remains about what should be shared, with whom and when. Currently, there is paucity in the literature about sharing interim trial data. This research project's intent is to better understand what kind of interim RCT data should be shared by the DSMB, if anything at all should be shared, with the PIs, the sponsor, or the steering committee during the RCT by: 1) Performing a systematic review on the topic of interim data sharing; 2) Exploring the statistical and informational properties of different items that can be shared at interim; 3) Creating a survey that will then be delivered to those who have involvement or interest in RCTs to elicit their opinions with sharing interim data and; 4) Exploring demographic variables of the respondents to determine factors that are associated with their responses. This research is vitally important to help in providing clear guidelines for RCT protocols and DSMB operating procedures, as sharing such interim information may have consequences in regards to biasing the final results of the trial. Regulatory agencies may also find this information helpful to guide those registering or conducting trials for drug approval.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Borg Debono, Victoria
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~